| MR编号 | NL/H/2447/002 |
|---|
| 药品名称 | Gemcitabine 38 mg/ml Concentrate for Solution for Infusion |
|---|
| 活性成分 | - gemcitabine hydrobromide 38.0 mg/ml
|
|---|
| 剂型 | Concentrate for solution for infusion |
|---|
| 上市许可持有人 | Fresenius Kabi Nederland BV
Amersfoortseweg 10E
3712BC Huis ter Heide
The Netherlands |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Gemcitabine Fresenius Kabi 38 mg/ml concentraat voor oplossing voor infusie |
|---|
| 互认成员国 - 产品名称 | - Slovakia (SK)
- Denmark (DK)
- Belgium (BE)
Gemcitabine Fresenius Kabi 38 mg/ml concentraat voor oplossing voor infusie (xx mg/xx ml) - Luxembourg (LU)
- Iceland (IS)
Gemkabi 38 mg/ml Innrennslisþykkni, lausn - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Gemcitabin Kabi 38 mg/ml Konzentrat zur Herstellung einer Infusionslösung - France (FR)
- Portugal (PT)
- Sweden (SE)
- Norway (NO)
Gemkabi - Finland (FI)
- Poland (PL)
- Latvia (LV)
Gemcitabine Kabi 38 mg/ml koncentrāts infūziju šķīduma pagatavošanai - Lithuania (LT)
Gemcitabine Kabi 38 mg/ml koncentratas infuziniam tirpalui - Estonia (EE)
GEMCITABINE KABI 38 MG/ML - Hungary (HU)
GEMCITABIN KABI 38 mg/ml koncentrátum oldatos infúzióhoz - Czechia (CZ)
GEMCITABINE KABI 38 MG/ML KONCENTRÁT PRO INFUZNÍ ROZTOK - Romania (RO)
Gemcitabina Kabi 38 mg/ml concentrat pentru soluţie perfuzabilă - Slovenia (SI)
- Malta (MT)
Gemcitabine 38 mg/ml concentrate for
|
|---|
| 许可日期 | 2014/10/15 |
|---|
| 最近更新日期 | 2024/02/13 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Line Extension
- TypeLevel2：Additional Strength/Form
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|